Updating results

1837 results

Sort: Relevance | Date

Acute illness in adults in hospital: surveillance consultation

We are listening to your views on this NICE guideline. Comments close 27 November 2019.

Clinical guideline In consultation

Self-harm in over 8s: management and preventing recurrence: draft scope consultation

We are listening to your views on this NICE guideline. Comments close 27 November 2019.

NICE guideline In consultation

Cyanoacrylate glue occlusion for varicose veins: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 21 November 2019.

Interventional procedures guidance In consultation

Minimally invasive radical hysterectomy for early stage cervical cancer: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 21 November 2019.

Interventional procedures guidance In consultation

Bilateral cervicosacropexy or vaginosacropexy using mesh for pelvic organ prolapse: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 21 November 2019.

Interventional procedures guidance In consultation

MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 21 November 2019.

Interventional procedures guidance In consultation

PneuX for preventing ventilator-associated pneumonia in intensive care: draft guidance

We are listening to your views on this medical technologies guidance. Comments close 06 December 2019.

In consultation

Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy [ID1536]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 05 December 2019.

Technology appraisal guidance In consultation

Human and animal bites: antimicrobial prescribing: draft guidance consultation

We are listening to your views on this antimicrobial prescribing guideline. Comments close 03 December 2019.

NICE guideline In consultation

Renal and ureteric stones: quality standard consultation

We are listening to your views on this quality standard. Comments close 04 December 2019.

Quality standard In consultation

Decision-making and mental capacity: quality standard consultation

We are listening to your views on this quality standard. Comments close 04 December 2019.

Quality standard In consultation

Asthma: diagnosis, monitoring and chronic asthma management: draft guidance consultation

We are listening to your views on this NICE guideline. Comments close 27 November 2019.

NICE guideline In consultation

Joint replacement (primary): hip, knee and shoulder: draft guidance consultation

We are listening to your views on this NICE guideline. Comments close 26 November 2019.

NICE guideline In consultation

Heavy menstrual bleeding (QS update): quality standard consultation

We are listening to your views on this quality standard. Comments close 16 December 2019.

Quality standard In consultation

Artificial iris implant insertion for acquired aniridia: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 19 December 2019.

Interventional procedures guidance In consultation

Artificial iris implant insertion for congenital aniridia: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 19 December 2019.

Interventional procedures guidance In consultation

Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 19 December 2019.

Interventional procedures guidance In consultation

Fremanezumab for preventing migraine [ID1368]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 06 December 2019.

Technology appraisal guidance In consultation

OTL-101 for treating adenosine deaminase deficiency–severe combined immunodeficiency [ID1152]

Proposed [GID-HST10022] Expected publication date: TBC

Highly specialised technologies guidance Proposed

VTS-270 for treating Niemann-Pick type C1 (ID1267)

Proposed [GID-HST10020] Expected publication date: TBC

Highly specialised technologies guidance Proposed

Esketamine for treatment-resistant depression (ID1414)

Proposed [GID-TA10371] Expected publication date: 18 March 2020

Technology appraisal guidance Proposed

Pitolisant hydrochloride for treating obstructive sleep apnoea ID1065

Proposed [GID-TA10385] Expected publication date: TBC

Technology appraisal guidance Proposed

Ravulizumab for treating paroxysmal nocturnal haemoglobinuria ID1457

Proposed [GID-HST10023] Expected publication date: TBC

Highly specialised technologies guidance Proposed

Rivaroxaban for treating chronic heart failure [ID1462]

Proposed [GID-TA10393] Expected publication date: TBC

Technology appraisal guidance Proposed

Lenadogene nolparvovec for treating Leber's hereditary optic neuropathy [ID1410]

Proposed [GID-TA10391] Expected publication date: TBC

Technology appraisal guidance Proposed

Upadacitinib for treating moderate to severe rheumatoid arthritis [ID1400]

Proposed [GID-TA10389] Expected publication date: 18 March 2020

Technology appraisal guidance Proposed

Fostamatinib for treating persistent or chronic immune thrombocytopenia [ID1087]

Proposed [GID-TA10387] Expected publication date: TBC

Technology appraisal guidance Proposed

Dabigatran etexilate for the secondary prevention of stroke after an embolic stroke of undetermined source (ID1417)

Proposed [GID-TA10426] Expected publication date: TBC

Technology appraisal guidance Proposed

Galcanezumab for preventing cluster headache [ID1212]

Proposed [GID-TA10425] Expected publication date: TBC

Technology appraisal guidance Proposed

Dulaglutide for treating type 2 diabetes [ID1451]

Proposed [GID-TA10439] Expected publication date: TBC

Technology appraisal guidance Proposed

Semaglutide for treating type 2 diabetes (ID1450)

Proposed [GID-TA10438] Expected publication date: TBC

Technology appraisal guidance Proposed

Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223

Proposed [GID-HST10019] Expected publication date: TBC

Highly specialised technologies guidance Proposed

Pegvaliase for treating phenylketonuria [ID1110]

Proposed [GID-TA10345] Expected publication date: TBC

Technology appraisal guidance Proposed

Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing elective surgery (ID1105)

Proposed [GID-TA10348] Expected publication date: TBC

Technology appraisal guidance Proposed

Tocilizumab for treating systemic sclerosis (ID1396)

Proposed [GID-TA10346] Expected publication date: TBC

Technology appraisal guidance Proposed

Rituximab for maintenance treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis [ID1320]

Proposed [GID-TA10332] Expected publication date: TBC

Technology appraisal guidance Proposed

Fingolimod for treating relapsing multiple sclerosis in children and young people [ID1378]

Proposed [GID-TA10336] Expected publication date: TBC

Technology appraisal guidance Proposed

Autologous haematopoietic stem cell transplantation for treating multiple sclerosis (ID1111)

Proposed [GID-TA10306] Expected publication date: TBC

Technology appraisal guidance Proposed

Intravenous zanamivir for treating influenza in hospital [ID1196]

Proposed [GID-TA10298] Expected publication date: TBC

Technology appraisal guidance Proposed

Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing elective surgery [ID1149]

Proposed [GID-TA10297] Expected publication date: TBC

Technology appraisal guidance Proposed

STG320 for treating persistent allergic rhinitis caused by house dust mites (ID1278)

Proposed [GID-TA10279] Expected publication date: TBC

Technology appraisal guidance Proposed

Mepolizumab for treating chronic obstructive pulmonary disease (ID1237)

Proposed [GID-TA10239] Expected publication date: TBC

Technology appraisal guidance Proposed

Avacopan for treating anti-neutrophil cytoplasmic antibody-associated vasculitis ID1178

Proposed [GID-TA10199] Expected publication date: TBC

Technology appraisal guidance Proposed

Dexamethasone intracanalicular insert for treating inflammation and pain after cataract surgery ID1154

Proposed [GID-TA10198] Expected publication date: TBC

Technology appraisal guidance Proposed

Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer (CDF Review TA600) ID1683

Proposed [GID-TA10537] Expected publication date: 12 August 2020

Technology appraisal guidance Proposed

Nivolumab for treating squamous cell carcinoma of the head and neck after platinum-based chemotherapy (CDF Review TA490) ID1585

Proposed [GID-TA10538] Expected publication date: 12 August 2020

Technology appraisal guidance Proposed

Ranibizumab for treating diabetic retinopathy [ID1592]

Proposed [GID-TA10521] Expected publication date: TBC

Technology appraisal guidance Proposed

Esketamine for treating major depressive disorder in adults at imminent risk for suicide ID1604

Proposed [GID-TA10518] Expected publication date: TBC

Technology appraisal guidance Proposed

Inebilizumab for treating neuromyelitis optica spectrum disorders [ID1529]

Proposed [GID-TA10522] Expected publication date: TBC

Technology appraisal guidance Proposed